27

Sep

2013

EU Commision New Rules For Auditing by NBs

0

The EU Commision published “COMMISSION RECOMMENDATIONof 24 September 2013 on the audits and assessments performed by notified bodies.

This clarifies and strengthens the criteria for certifying (and auditing) notified bodies and the criteria that the notified bodies have to use in assessing companies and products.

The main changes are that the member states are required to do a joint assessment of a potential notified body with experts from the Commission and to carry out surveillance and monitoring of notified bodies. It also requires notified bodies to do unannounced factory audits which they were not allowed to do before (but the FDA
does).

It also states “As publication of residual risks in the information given to the user does not reduce the risk, but publication of residual risks and warnings used as risk
control measure may be beneficial, have residual risks been correctly placed on IFUs or provided in training, and have manufacturers evaluated whether those warnings are effective…” This clarifies that although labeling cannot reduce risk labelling can still be used as risk control measures.

Being Agile & Yet Compliant (Public)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for registration!

Agile principles that align well with medical
Backlog management
Agile risk management
Incremental and iterative software development lifecycle management
Frequent release management
And more!

3 days virtual (Zoom) with group exercises, quizzes, examples, Q&A.

Lead Instructor: Mike Russell

Next public offerings:

Americas: 11-13 February 2025
EU/Eastern Europe/Middle East/Africa/Atlantic/eastern South America: 18-20 February 2025
Southern Central Northeastern Pacific: 24-26 February 2025

Register using form at this link: Agile Course Post Promo

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future. Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply. Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering: TBD

Call or email now to schedule a private, in-house class. The fall schedule is filling up!

Email training@softwarecpr.com to request a special pre-registration discount. Limited number of pre-registration coupons.

Registration Link:

TBD

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering: TBD